Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Simon Alberti - , Whitehead Institute for Biomedical Research (Author)
  • Randal Halfmann - , Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology (MIT) (Author)
  • Susan Lindquist - , Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology (MIT), Howard Hughes Medical Institute (Author)

Abstract

Protein aggregates are associated with a variety of debilitating human diseases, but they can have functional roles as well. Both pathological and nonpathological protein aggregates display tremendous diversity, with substantial differences In aggregate size, morphology, and structure. Among the different aggregation types, amyloids are particularly remarkable, because of their high degree of order and their ability to form self-perpetuating conformational states. Amyloids form the structural basis for a group of proteins called prions, which have the ability to generate new phenotypes by a simple switch in protein conformation that does not involve changes in the sequence of the DNA. Although protein aggregates are notoriously difficult to study, recent technological developments and, in particular, the use of yeast prions as model systems, have been very instrumental in understanding fundamental aspects of aggregation. Here, we provide a range of biochemical, cell biological and yeast genetic methods that are currently used In our laboratory to study protein aggregation and the formation of amyloids and prions.

Details

Original languageEnglish
Pages (from-to)709-734
Number of pages26
JournalMethods in Enzymology
Volume470
Issue numberC
Publication statusPublished - 2010
Peer-reviewedYes
Externally publishedYes

External IDs

ORCID /0000-0003-4017-6505/work/161409871

Keywords

Sustainable Development Goals

ASJC Scopus subject areas